De novo assay development holds great promise for future drug discovery projects, potentially reducing costs, improving success rates, and ultimately benefiting patients by accelerating the development of safe and effective therapeutics. Download our white paper to learn what you need to know with regard to new biomarker assay development.

In this white paper, discover enhanced polysorbate analysis with mixed-mode HPLC. Download now.

Using mass spectrometry to identify and quantify HCPs enables a more rational development of robust purification processes.